ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

2016 ACR/ARHP Annual Meeting

November 11-16, 2016. Washington, DC.

View by Number View by Title View Sessions
View by Date

Monday, November 14, 2016

4:30PM-6:00PM
Abstract Number: 2033
A Multi-Dimensional Genomic Map for Polyarticular Juvenile Idiopathic Arthritis
Genetics, Genomics and Proteomics I
4:30PM-6:00PM
Abstract Number: 2066
Anti-Ds-DNA Antibodies Regulate Atherothrombosis in Systemic Lupus Erythematosus through the Induction of Netosis, the Prothrombotic and Proinflammatory Activities of Monocytes and the Endothelial Activation
Systemic Lupus Erythematosus – Human Etiology and Pathogenesis I
4:30PM-6:00PM
Abstract Number: 2026
Are Adult Trajectories of Weight over a Lifetime Linked to Foot Problems Years Later?
ACR/ARHP Combined Abstract Session: Epidemiology and Pubic Health
4:30PM-6:00PM
Abstract Number: 2039
Assessing Barriers to Uveitis Screening in Patients with JIA: A Qualitative Study
Quality Measures and Quality of Care I
4:30PM-6:00PM
Abstract Number: 2060
Bim Suppresses the Development of SLE By Limiting Macrophage Inflammatory Responses
Systemic Lupus Erythematosus – Animal Models
4:30PM-6:00PM
Abstract Number: 2064
Blood and Kidney Molecular Profiles Distinguish Subjects with Lupus Nephritis from Other Kidney Disorders
Systemic Lupus Erythematosus – Human Etiology and Pathogenesis I
4:30PM-6:00PM
Abstract Number: 2056
Choroid Plexus Infiltrates in Lupus Model (MRL/lpr) Mice Represent Tertiary Lymphoid Structures, Shedding Light on the Immunological Mechanisms of Neuropsychiatric Lupus
Systemic Lupus Erythematosus – Animal Models
4:30PM-6:00PM
Abstract Number: 2083
Comparing the Electronic Patient Reported Outcome (ePro) Tool Versus the Paper Reported Outcome (pPro) Tool in Rheumatoid Arthritis Patients Treated with Certolizumab Pegol
ARHP IV: Clinical Practice, Patient Care and Health Services
4:30PM-6:00PM
Abstract Number: 2067
Dermal Fibroblasts from Patients with Lupus Nephritis Express an Anti-Fibrotic Transcriptome
Systemic Lupus Erythematosus – Human Etiology and Pathogenesis I
4:30PM-6:00PM
Abstract Number: 2081
Dermal Temperature Is an Excelent Prognostic Indicator to Guide RA Therapy
ARHP IV: Clinical Practice, Patient Care and Health Services
4:30PM-6:00PM
Abstract Number: 2031
Dietary Patterns and Radiographic Progression of Knee Osteoarthritis: Data from the Osteoarthritis Initiative
ACR/ARHP Combined Abstract Session: Epidemiology and Pubic Health
4:30PM-6:00PM
Abstract Number: 2030
Difference in Risk Factor Profile Between Medial and Lateral Compartment Involvement in Tibiofemoral Knee Osteoarthritis
ACR/ARHP Combined Abstract Session: Epidemiology and Pubic Health
4:30PM-6:00PM
Abstract Number: 2069
Dipeptidyl-Peptidase-4 (DPP4) Positive Fibroblast Subpopulation Promotes Fibrosis and Are a Molecular Target for Treatment of Fibrosis
Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Pathogenesis, Animal Models and Genetics I
4:30PM-6:00PM
Abstract Number: 2035
Dosage Contribution of a Non-Classical HLA Gene, HLA-Doa, to the Risk of Rheumatoid Arthritis
Genetics, Genomics and Proteomics I
4:30PM-6:00PM
Abstract Number: 2045
Early Preeclampsia Risk in Lupus Pregnancy: A Swedish Population-Based Register Investigation
Reproductive Issues in Rheumatic Disorders
  • «Previous Page
  • 1
  • …
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • Next Page»
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology